San Jia Fu Mai Tang (Three Shell Decoction to Restore the Pulse)

Actions

Indications

Western Uses:

• What is San Jia Fu Mai Tang used for in modern practice?

  In modern practice San Jia Fu Mai Tang is referenced for late-stage febrile neurological illness and conditions involving deficiency-driven neuromuscular hyperexcitability. It has historically been discussed alongside encephalitis and meningitis convalescence, and a recent clinical case series used it (combined with Shaoyao-Gancao decoction) for Morvan syndrome — a rare autoimmune disorder causing neuromyotonia (muscle twitching/stiffness), hyperhidrosis, and sleep disturbance, treated there as a yin-deficiency pattern. Separately, it has been studied preclinically as a candidate neuroprotective agent in a Parkinson’s-disease cell and animal model.

  These biomedical correlates are offered as a reference to the formula’s traditional use, not a claim that it treats any diagnosed disease; current evidence is limited to one clinical case series plus preclinical work (see research). Any use for a diagnosed condition belongs with a qualified practitioner and appropriate medical care.

  Source: traditional-use correlates cross-referenced with PubMed 39432629 and DOI 10.4103/wjtcm.wjtcm_62_20; reference only, not a treatment claim.

Originally Appeared In:

• Systematic Differentiation of Warm Diseases (Wen Bing Tiao Bian)

Notes:

• How is San Jia Fu Mai Tang different from Jia Jian Fu Mai Tang, Er Jia Fu Mai Tang, and Da Ding Feng Zhu?

  San Jia Fu Mai Tang is the strongest of Wu Jutong’s escalating “Fu Mai Tang” series, built by adding all three shells to the base formula as yin depletion deepens. Wu Jutong derived the whole series from Zhang Zhongjing’s classical Zhi Gan Cao Tang (“Fu Mai Tang”) by removing its qi- and yang-tonifying herbs (Ren Shen, Gui Zhi, Sheng Jiang, Da Zao) — unsuited once heat has damaged yin — adding Bai Shao, and substituting dry for cooked Rehmannia, to form Jia Jian Fu Mai Tang, the shared base of the series.

  • vs Jia Jian Fu Mai Tang: the unmodified base (six herbs, no shells) for straightforward yin/fluid depletion after aggressive heat-purging, without signs of rising yang.
  • vs Yi Jia / Er Jia Fu Mai Tang: intermediate steps in the same series that add Mu Li alone, then Mu Li plus Bie Jia, for progressively deeper yin loss with early signs of yang floating upward.
  • vs Da Ding Feng Zhu: Da Ding Feng Zhu is Jia Jian Fu Mai Tang plus all three shells and Wu Wei Zi and raw egg yolk (Ji Zi Huang) — reserved for the most severe cases, with frank tremors, spasms, or impending collapse, where San Jia Fu Mai Tang’s yin-and-yang-anchoring is not yet enough.

  Source: cross-referenced Wen Bing Tiao Bian formula-lineage summaries (Chinese-language pharmacopedia references and multiple online sources) + Bensky & Barolet, Formulas & Strategies comparison framework.

Clinical Studies & Research:

• Is there modern research on San Jia Fu Mai Tang?

  Modern research on San Jia Fu Mai Tang specifically is sparse — one published clinical case series and one preclinical neuroprotection study are the strongest PubMed-verifiable evidence, with broader Chinese-language claims (arrhythmia, osteoporosis) not independently confirmed here. A 2024 case series describes Sanjia-Fumai decoction, combined with Shaoyao-Gancao decoction as a yin-deficiency-pattern treatment, alongside symptomatic improvement in three patients with Morvan syndrome (a rare autoimmune neuromyotonia disorder). A separate preclinical study found a San-Jia-Fu-Mai decoction extract reduced oxidative-stress markers in MPP+-treated PC12 cells and improved motor deficits and striatal dopamine levels in an MPTP mouse model of Parkinson’s disease.

  • Clinical case series: Sanjia-Fumai decoction (with Shaoyao-Gancao decoction) for Morvan syndrome, 3 cases (PMID 39432629).
  • Preclinical (Parkinson’s-disease model): San-Jia-Fu-Mai decoction extract reduced ROS/MDA and improved motor function in PC12-cell and MPTP-mouse models (DOI 10.4103/wjtcm.wjtcm_62_20, World Journal of Traditional Chinese Medicine, 2021).

  Sources: PubMed 39432629; DOI 10.4103/wjtcm.wjtcm_62_20. Research context only, not a therapeutic claim; direct clinical-trial evidence for the formula as a whole remains very limited.